Kinetic analysis of the humoral immune response against 3 Toxoplasma gondii-recombinant proteins in infants with suspected congenital toxoplasmosis

Diagnostic Microbiology and Infectious Disease

Volumn 56, Issue 2, 2006, Pages 161-165

  Altcheh, Jaime ^a   Diaz, Natalia S ^a   Pepe, Carolina M ^a   Martin, Valentina ^b,c   Nigro, Monica ^b   Freilij, Hector ^a   Angel, Sergio O ^c  

^a HOSPITAL DE NIÑOS RICARDO GUTIÉRREZ   (Argentina)

^b Administracion Nacional de Laboratorios E Institutos de Salud Dr Carlos G Malbran   (Argentina)

^c INSTITUTO DE INVESTIGACIONES BIOTECNOLÓGICAS   (Argentina)

Author keywords

Congenital toxoplasmosis; Diagnosis; Recombinant protein; Toxoplasma gondii

Indexed keywords

GRA4 PROTEIN; GRA7 PROTEIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; RECOMBINANT ANTIGEN; RECOMBINANT PROTEIN; ROP2 PROTEIN; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLOW UP; HUMAN; HUMORAL IMMUNITY; IMMUNOREACTIVITY; INFANT; KINETICS; PRIORITY JOURNAL; TOXOPLASMA GONDII; TOXOPLASMOSIS;

AGING; ANIMALS; ANTIBODY FORMATION; ANTIGENS, PROTOZOAN; ANTIPROTOZOAL AGENTS; GENE EXPRESSION REGULATION; HUMANS; IMMUNOGLOBULIN G; INFANT; INFANT, NEWBORN; KINETICS; LEUCOVORIN; PYRIMETHAMINE; RECOMBINANT PROTEINS; SENSITIVITY AND SPECIFICITY; SULFADIAZINE; TOXOPLASMA; TOXOPLASMOSIS, CONGENITAL;

EID: 33749480930     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2006.03.012     Document Type: Article

References (16)

1. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
2. Gross U., Lüder C.G.K., Hendgen V., Heeg C., Sauer I., Weidner A., Krczal D., and Enders G. Comparative immunoglobulin G antibody profiles between mother and child (CGMC test) for early diagnosis of congenital toxoplasmosis. J. Clin. Microbiol. 38 (2000) 3619-3622
3. Jacobs D., Vercammen M., and Saman E. Evaluation of recombinant dense granule antigen 7 (GRA7) of Toxoplasma gondii for detection of immunoglobulin G antibodies and analysis of a major antigenic domain. Clin. Diagn. Lab. Immunol. 6 (1999) 24-29
4. Li S., Maine G., Suzuki Y., Araujo F.G., Galvan G., Remington J.S., and Parmley S. Serodiagnosis of recently acquired Toxoplasma gondii infection with a recombinant antigen. J. Clin. Microbiol. 38 (2000) 179-184
5. Li S., Galvan G., Araujo F.G., Suzuki Y., Remington J.S., and Parmley S. Serodiagnosis of recently acquired Toxoplasma gondii infection using an enzyme-linked immunosorbent assay with a combination of recombinant antigens. Clin. Diagn. Lab. Immunol. 7 (2000) 781-787
6. Martin V., Arcavi M., Amendoeira M.R.R., de Souza Neves E., Santillán G., Guarnera E., Garberi J.C., and Angel S.O. Detection of human anti-Toxoplasma specific immunoglobulins A, M and G by a recombinant Toxoplasma gondii Rop2 protein. Clin. Diagn. Lab. Immunol. 5 (1998) 627-631
7. Mc Auley J., Boyer K.M., Patel D., Mets M., Swisher C., Roizen N., Wolters C., Stein L., Stein M., and Schey W. Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: the Chicago collaborative treatment trial. Clin. Infect. Dis. 18 (1994) 38-72
8. Nielsen H.V., Schmidt D.R., and Petersen E. Diagnosis of congenital toxoplasmosis by two-dimensional immunoblot differentiation of mother and child immunoglobulin G profiles. J. Clin. Microbiol. 43 (2005) 711-715
9. Nigro M., Martin V., Kaufer F., Carral L., Angel S.O., and Pszenny V. High level of expression of the Toxoplasma gondii-recombinant Rop2 protein in Escherichia coli as a soluble form for optimal use in diagnosis. Mol. Biotechnol. 18 (2001) 269-273
10. Nigro M., Gutierrez A., Hoffer A.M., Clemente M., Kaufer F., Carral L., Martin V., Guarnera E.A., and Angel S.O. Evaluation of Toxoplasma gondii recombinant proteins for the diagnosis of recently acquired toxoplasmosis by an immunoglobulin G analysis. Diagn. Microbiol. Infect. Dis. 47 (2003) 609-613
11. Pietkiewicz H., Hiszczynska-Sawicka E., Kur J., Petersen E., Nielsen H.V., Stankiewicz M., Andrzejewska I., and Myjak P. Usefulness of Toxoplasma gondii-specific recombinant antigens in serodiagnosis of human toxoplasmosis. J. Clin. Microbiol. 42 (2004) 1779-1781
12. Pinon J.M., Chemla C., Villena I., Foudrinier F., Aubert D., Puygauthier-Toubas D., Leroux B., Dupouy D., Quereux C., Talmud M., Trenque T., Potron G., Pluot M., Remy G., and Bonhomme A. Early neonatal diagnosis of congenital toxoplasmosis: value of comparative enzyme-linked immunofiltration assay, immunological profiles and anti-Toxoplasma gondii immunoglobulin M (IgM) or IgA immunocapture and implications for postnatal therapeutic strategies. J. Clin. Microbiol. 34 (1996) 579-583
13. Pinon J.M., Dumon H., Chemla C., Franck J., Petersen E., Lebech M., Zufferey J., Bessieres M.-H., Marty P., Holliman R., Johnson J., Luyasu V., Lecolier B., Guy E., Joynson D.H.M., Decoster A., Enders G., Pelloux H., and Candolfi E. Strategy for diagnosis of congenital toxoplasmosis: evaluation of methods comparing mothers and newborns and standard methods for postnatal detection of immunoglobulin G, M, and A antibodies. J. Clin. Microbiol. 39 (2001) 2267-2271
14. Remington J.S., McLeod R., Thulliez P., and Desmonts G. Toxoplasmosis. In: Remington J.S., and Klein J.O. (Eds). Infectious Diseases of the Fetus and Newborn Infant. 5th ed. (2001), The WB Saunders Co., Philadelphia 205-346
15. Tenter A.M., Heckeroth A.R., and Weiss L.M. Toxoplasma gondii: from animals to humans. Int. J. Parasitol. 30 (2000) 1217-1258
16. Wilson C.B., Remington J.S., Stagno S., and Reynolds D.W. Development of adverse sequelae in children born with subclinical congenital Toxoplasma infection. Pediatrics 66 (1980) 767-774